Navigation Links
Cardium Launches New AWARE Clinical Study Website
Date:6/11/2008

SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) today announced the launch of a new website at http://www.anginaresearchstudy.com to provide patients, caregivers and physicians with information about the Company's Phase 3 AWARE clinical study. The AWARE study is evaluating the therapeutic effects of Generx(TM) for the potential treatment of myocardial ischemia (insufficient blood flow within the heart muscle) and associated angina due to coronary heart disease. Generx is designed to promote angiogenesis, a natural process of blood vessel growth within the heart muscle, following a one-time intracoronary infusion from a standard cardiac infusion catheter.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

The AWARE (Angiogenesis in Women with Angina pectoris who are not candidates for Revascularization) study, a Phase 3 randomized, placebo-controlled, double-blind trial, is planned to enroll approximately 300 women with recurrent stable angina pectoris who are not candidates for revascularization and who are receiving optimal drug therapy. The primary endpoint is the improvement in time to onset of electrocardiogram changes diagnostic of myocardial ischemia during exercise treadmill testing at six months following administration. The secondary endpoints are improvement in myocardial blood flow within the affected heart muscle measured by adenosine SPECT imaging, as well as improvements in other measures of angina. The AWARE study is expected to include up to 50 U.S. clinical centers. Enrollment criteria, participating sites and other info
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
11. Novozymes Launches Enzyme to Reduce Acrylamide in Food

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...USNewswire/ -- The Appignani Bioethics Center, a p...a panel discussion today at the National Press Clu...n biomedical sciences and climate change. The topi..., both of the Center for American Progress, who co...les. ,, A video of the event will be made avai...
(Date:11/9/2009)...ber 9 For more than 20 years,resea... development of a,Brain-Computer Interface (BCI). ... brain and a computer. Such a system enables compl...rol devices in their environment just by,mental ac...een supervised by,the researchers themselves to us...
(Date:11/9/2009)... top 10 pharmaceutical giants use Datafarm for pro...a. Datafarm’s announcement comes on the heel...ting where Health Canada stated that, effective im...D regulatory submissions for New Drug Submission (.... , Marlborough, MA (PRWE...
(Date:11/8/2009)...5, 2009 Complete Genomics, a third-generation hum...ication of a report in the journal Science descr...luding analysis of sequence data from three comple...hree genomes sequenced on the proof-of-principle g...overage to $1,726 for 45x coverage for the samples...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
...w Generation,Biofuels Holdings, Inc. (Nasdaq: NGB...hat David Gillespie, President & CEO, is scheduled...Investment Conference on Monday,November 10th, at ...able,for one-on-one meetings during the day. The c...l in New York City. The presentation will be webca...
...oGenomics, Inc.,(OTC Bulletin Board: NGNM) announc...er, Bob Gasparini, will present at the Rodman & Re... from November 10-12, 2008 at,the New York Palace ...se,over 350 small and microcap public life science...r executives of attending companies will make,pres...
...orporation (Nasdaq:,DNDN) today reported results f...or the third quarter of 2008 was $26,000 compared ...07. Revenue for the nine months ended,September 30...ne months,ended September 30, 2007., Dendreon,s t...008 were,$17.3 million compared to $19.8 million i...
Other Biology Technology:New Generation Biofuels CEO to Present at the Rodman & Renshaw Annual Global Investment Conference 2NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10 2Dendreon Reports Third Quarter 2008 Financial Results 2Dendreon Reports Third Quarter 2008 Financial Results 3Dendreon Reports Third Quarter 2008 Financial Results 4Dendreon Reports Third Quarter 2008 Financial Results 5
(Date:11/9/2009)...HILADELPHIA Scientists and industry leaders from ... 2009, for the AACR-NCI-EORTC Molecular Targets an...ich will feature groundbreaking information on imp...er is a complex disease and to treat it effectivel...that takes place at the molecular level," said Lew...
(Date:11/8/2009)... HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTEL... LIVES , An Indiana University study involving ...he adults increased their personal health knowledg... , Adults with ID, an internationally accepted ...rates of obesity, physical inactivity and preventa...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, M...LEID) will be installing its locker system and pat...ACS) at the U.S. Department of Health and Human Se...in Bethesda, MD. The locker system will support t...or protecting our nation,s medical research agency...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Bio enabled surface mediated approach produces nanoparticle composites 13633 1Bio enabled surface mediated approach produces nanoparticle composites 13633 2Bio enabled surface mediated approach produces nanoparticle composites 13633 3Living longer and happier 54930 1Living longer and happier 54930 2Kaiser Workers Launch Statewide Pickets 54929 1
... Depression, anxiety disorders such as panic diso...and drug dependence, dementia and Parkinsons disea...ain. The size, the burden and cost of brain disord...erestimated, as Prof. Dr. Hans Ulrich Wittchen ,em...0th ECNP Congress for ,Neuropsychopharmacology in ...
... Even early in adulthood, aging begins to slow th... altogether, suggests a Princeton University study...roscientists has found that soon after marmoset mo...l cells form in the hippocampus region of the anim...associated with both learning and memory. While ot...
... PHILADELPHIA, PA, October 15, 2007- Clinical dat...rican College of Gastroenterology (ACG) show that ...lectomy surgeries for patients with moderately to ...g to a primary analysis of long-term extension dat...s (ACT trials), there is a 41 percent reduction in...
Other Biology News:Mental disorders are disorders of the brain 2Mental disorders are disorders of the brain 3Brain cell growth diminishes long before old age strikes, animal study shows 2Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 2Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 3Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 4Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 5Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 6
Agilent ChemStation Base Software from Agilent Technologies
Mouse Anti-HLA, Class II Antigen-DR+DP Monoclonal Antibody, Unconjugated, Clone 236-14240 from Meridian Life Science, Inc.
...lly clear polystyrene with frosted labeling surfac...s for cell counting. 100% integrity tested. Linkag...d to easily match Cornings product number. If show...d Sigma-Aldrich number (C0177) or contact customer...
Rabbit Anti-iNOS / NOS Type II Polyclonal Antibody, Unconjugated from BD Biosciences Pharmingen
Biology Products: